Rua Bioscience Limited — Major Shareholding Notification 2020

Oct 22, 2020

DISCLOSURE OF BEGINNING TO HAVE SUBSTANTIAL HOLDING

Section 276, Financial Markets Conducts Act 2013

To NZX Limited (NZX)

and

To Rua Bioscience Limited

Date this disclosure made: 22 October 2020

Date on which substantial holding began: 22 October 2020

Substantial product holder(s) giving disclosure

Full name(s): Hikurangi Bioactives Limited Partnership ( HBLP

Hikurangi Bioactives GP Limited ( HBGPL )

Summary of substantial holding

Class of quoted voting products: ordinary shares in Rua Bioscience Limited (NZX Code: RUA) Summary for: HBLP and HBGPL

For this disclosure:

• a) total number held in class: 23,488,787

• b) total in class: 140,012,225

• c) total percentage held in class: 16.776%

Details of relevant interests

Details for HBLP

Nature of relevant interest(s): Registered holder and beneficial owner of the shares.

For that relevant interest,–

• a) number held in class: 23,488,787

• b) percentage held in class: 16.776%

• c) current registered holder(s): HBLP

• d) registered holder(s) once transfers are registered: Not applicable

• For a derivative relevant interest, also –

• a) type of derivative: Not applicable

• b) details of derivative: Not applicable

• c) parties to the derivative: Not applicable

• d) if the substantial product holder is not a party to the derivative, the nature of the relevant interest in the derivative: Not applicable

Details for HBGPL

Nature of relevant interest(s): HBGPL has the responsibility, authority and power for the management and control of the business and affairs of HBLP as its general partner, and accordingly has a relevant interest in HBLP’s shares in Rua Bioscience Limited.

For that relevant interest,–

• a) number held in class: 23,488,787

• b) percentage held in class: 16.776%

• c) current registered holder(s): HBLP

• d) registered holder(s) once transfers are registered: Not applicable

• For a derivative relevant interest, also –

• a) type of derivative: Not applicable

• b) details of derivative: Not applicable

• c) parties to the derivative: Not applicable

• d) if the substantial product holder is not a party to the derivative, the nature of the relevant interest in the derivative: Not applicable

Details of transactions and events giving rise to substantial holding

Details of the transactions or other events requiring disclosure: HBLP and HBGPL each became a substantial product holder upon Rua Bioscience Limited’s ordinary shares being quoted on the NZX Main Board on 22 October 2020.

Additional information

Address(es) of substantial product holder:

HBLP: 6434 Waiapu Road, Rd 1, Ruatoria, 4081, New Zealand

HBGPL: c/o Coates Associates Limited, 300 Childers Road, Gisborne, Gisborne, 4010, New Zealand

Contact details: Joshua Woo +64 9 309 1445 jow@lojo.co.nz

Nature of connection between substantial product holders: HBLP and HBGPL are associated persons under section 12(1) of the Financial Markets Conduct Act 2013.

Name of any other person believed to have given, or believed to be required to give, a disclosure under the Financial Markets Conduct Act 2013 in relation to the financial products to which this disclosure relates: Rua Bioscience Limited

Certification

I, Damian Skinner, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.